TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotech-IgG Equity AB (publ)
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 11,618 | 5,399 | 20,593 |
Financial expenses | 3,891 | 526 | 955 |
Earnings before taxes | -81,195 | 2,190 | -4,727 |
EBITDA | 904 | -664 | -3,723 |
Total assets | 84,712 | 170,010 | 9,521 |
Current assets | 26,747 | 16,171 | 8,811 |
Current liabilities | 29,061 | 44,321 | 2,884 |
Equity capital | 52,145 | 125,690 | 5,432 |
- share capital | 72,075 | 67,903 | 8,790 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 61.6% | 73.9% | 57.1% |
Turnover per employee | 5,809 | 2,700 | 10,296 |
Profit as a percentage of turnover | -698.9% | 40.6% | -23.0% |
Return on assets (ROA) | -91.3% | 1.6% | -39.6% |
Current ratio | 92.0% | 36.5% | 305.5% |
Return on equity (ROE) | -155.7% | 1.7% | -87.0% |
Change turnover | 6,381 | -13,771 | -20,629 |
Change turnover % | 122% | -72% | -50% |
Chg. No. of employees | 0 | 0 | -1 |
Chg. No. of employees % | 0% | 0% | -33% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.